Radiofrequency catheter ablation of atrial fibrillation (AF) is an effective rhythm control strategy, and its efficacy has been proved to be superior to anti-arrhythmic drugs.1-3) Recently, the European Society of Cardiology's 2010 revised guidelines for AF management suggested catheter ablation as the first-line treatment in patients with paroxysmal lone AF.4) When Haissaguerre et al.5) initially reported catheter ablation of AF, it was focal ablation of the pulmonary vein (PV) origin of AF. The rationale for PV ablation was the existence of arrhythmogenic Purkinje fibre-like cells inside the PV,6) and reproducible PV triggers initiating AF.7) In 2002, multipolar circular ring catheter for mapping of the PV was introduced in performing catheter ablation of AF. Multipolar ring catheter is useful for the detection of arrhythmogenic PV and specific localization of foci triggering AF.8) Therefore, multipolar circular ring catheter guided segmental ostial ablation of arrhythmogenic PV was the standard therapy for AF ablation in the early and mid 2000s. However, there is a substantial risk of PV stenosis associated with ostial ablation after RF energy delivery. Therefore to reduce the risk of PV stenosis, the ablation strategy has changed to circumferential PV isolation at the level of PV antrum, which is 10-15 mm outside the PV ostium.9) Although reproducibly defined arrhythmogenic PV isolation demonstrates a clinical outcome comparable with empirical 4-PV isolation,10) most of the patients with AF who underwent catheter ablation have multiple PV foci in multiple veins and hence circumferential bi-antral ablation with electrical isolation of 4 PVs became the cornerstone of catheter ablation of AF.
Meanings of Pulmonary Vein Isolation
In 2000, Pappone et al.11) reported that anatomically guided circumferential PV ablation without monitoring the PV potential is good enough for catheter ablation of AF. In their technique, high-power radiofrequency energy was delivered and additional linear ablation was performed.11) Although an outstanding clinical outcome with short procedure time was reported, this technique was not reproducible among other invasive electrophysiologists. In spite of such limitations, this linear ablation design is still being used in many other electrophysiology institutes for the ablation of long-standing persistent AF.12)Currently, many electrophysiologists are using a compromised technique for circumferential ostial PV isolation and anatomical wide area circumferential PV ablation; wide circumferential PV isolation.13) As compared with segmental ostial ablation, wide circumferential PV isolation targets the peri-PV ostial triggers or drivers, ganglionate plexi, and critical mass reduction,14)15) as well as the elimination of PV triggers. Therefore, elimination of PV potentials has the effect of a significant conduction delay or enough radiofrequency energy delivery around the PV antrum, rather PV isolation itself has an anti-arrhythmic effect.
Multipolar Ring Catheter Guided Antral Ablation
As compared with anatomically guided antral ablation without monitoring of the PV potential,11) multipolar catheter guided circumferential PV isolation shows a change in the PV potential sequence or PV conduction delay. Therefore, multipolar circular ring catheter provides the location of critical preferential conduction between the left atrium and PV, and minimizes unnecessary radiofrequency energy delivery. However, the main limitation of multipolar ring catheter guided ablation is the discrepancy of a distance of 10-15 mm between the ablation site and mapping site. Therefore, the elimination of PV potential is an indirect reflection of enough radiofrequency energy delivery around the PV antrum. To reduce this discrepancy, Jang et al.16) reported the efficacy and feasibility of 30-35 mm diameter, large-sized, multipolar ring catheter for circumferential antral ablation. This large-diameter, multipolar circular catheter is designed for mapping of the PV antrum by direct contact. The large-sized, circumferential ring catheter guided antral ablation and anatomically guided antral ablation utilizing three-dimensional electroanatomical mapping were compared, and the superiority of large-sized ring catheter mapping in terms of the immediate PV isolation success rate and short-term clinical outcome was reported. It was a reasonable result proving the superiority of antral potential mapping compared with anatomically guided ablation of AF, but the large-sized, circular mapping catheter and the conventional 25-mm circular mapping catheter for circumferential PV isolation were not compared in this study. In contrast, the large-sized circumferential ring catheter may reduce the discrepancy by monitoring the antral potential, however, it might be difficult to maintain catheter stability because the antral shape is not circular but rather elliptical. Large-sized, multipolar ring catheter sometimes cannot monitor the PV potential or potential in the ligament of Marshall, because PV potential is maintained by epicardial conduction after antral ablation in some patients. There is some risk of char formation at the contact surface between the mapping catheter and radiofrequency ablation catheter due to the "edge effect". Therefore, additional study comparing the large-sized and the conventional circular mapping catheters is warranted in the future.
Conclusion
Circumferential PV ablation became the cornerstone of catheter ablation of AF. Although the pathophysiology of AF is being uncovered with the development of ablation technology of AF, a more effective and safer mapping or ablation technology is required to improve the clinical outcome. We expect fast and efficient catheter technology, such as duty-cycled, large-sized circular ring catheter17) for mapping and ablation of the PV antrum in the future. It appears that conventional contact mapping by a well-designed mapping catheter assumed more importance in catheter ablation of AF than high-technology three-dimensional computer processed image guided mapping; back to the future.
Authors: Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady Journal: N Engl J Med Date: 2006-03-02 Impact factor: 91.245
Authors: Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs Journal: J Cardiovasc Electrophysiol Date: 2005-11
Authors: Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale Journal: JAMA Date: 2005-06-01 Impact factor: 56.272
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245
Authors: Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady Journal: Circulation Date: 2003-10-13 Impact factor: 29.690
Authors: Hui-Nam Pak; Jin Seok Kim; Seung Yong Shin; Hyun Soo Lee; Jong Il Choi; Hong Euy Lim; Chun Hwang; Young-Hoon Kim Journal: J Cardiovasc Electrophysiol Date: 2008-02-12
Authors: Girish M Nair; Pablo B Nery; Syamkumar Diwakaramenon; Jeffrey S Healey; Stuart J Connolly; Carlos A Morillo Journal: J Cardiovasc Electrophysiol Date: 2008-09-03